Table 2B:
Clinical Outcomes in Hemodialysis (HD)-Dependent vs Non-HD-Dependent Patients with MRSA Bacteremia
| HD-Dependent | Non-HD-Dependent | P-value | |
|---|---|---|---|
| n=206 | n=898 | ||
| All-Cause Mortality (%) | 65 (31.6) | 288 (32.1) | 0.9 |
| SAB a -Attributable Mortality (%) | 35 (17.0) | 163 (18.2) | 0.8 |
| Persistent Bacteremia (%) | 91 (44.2) | 235 (26.2) | <0.001 |
| Metastatic Complications (Overall) (%) | 84 (40.8) | 327 (36.5) | 0.3 |
| Metastatic Abscess (%) | 16 (7.8) | 86 (9.6) | 0.5 |
| Psoas Abscess (%) | 4 (1.9) | 19 (2.1) | 0.9 |
| Epidural Abscess (%) | 4 (1.9) | 25 (2.8) | 0.6 |
| Endocarditis (%) | 41 (19.9) | 114 (12.7) | 0.01 |
| Vertebral Osteomyelitis (%) | 9 (4.4) | 36 (4.0) | 0.9 |
| Septic Arthritis (%) | 9 (4.4) | 55 (6.1) | 0.4 |
| Septic Emboli (%) | 15 (7.3) | 56 (6.3) | 0.6 |
| Septic Thrombophlebitis (%) | 18 (8.7) | 34 (3.8) | 0.01 |
P-values marked in bold are significant.
a
Staphylococcus aureus-bacteremia